• Personal Stories
• Science & Technology

A lasting legacy after melanoma: Mark’s story

When Dave Sims’s brother Mark was diagnosed with terminal melanoma, our study helped him leave a lasting legacy. When Dave Sims’s brother Mark was diagnosed with terminal melanoma, our study helped him leave a lasting legacy.

25 September 2025

• For Researchers

The challenges of going international for CYP

International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges… International trials are vital to children’s and young people’s cancer research but can be notoriously difficult to set up. We get into the challenges…

24 September 2025

• Charity News
• Health & Medicine
• Science & Technology

The latest teams bidding for up to £20m to tackle cancer's greatest challenges

Cancer Grand Challenges has announced the 12 latest teams competing for up for £20 million each to bring their research to life. Cancer Grand Challenges has announced the 12 latest teams competing for up for £20 million each to bring their research to life.

24 September 2025

• Policy & Insight

How Scotland and Wales can save thousands of lives from cancer

We've published our manifestos for cancer research and care in Scotland and Wales. They can help both countries reduce cancer death rates by 15% by 2040. We've published our manifestos for cancer research and care in Scotland and Wales. They can help both countries reduce cancer death rates by 15% by 2040.

24 September 2025

• Policy & Insight

What Denmark (and Lego) can teach us about improving cancer survival

Cancer survival in Denmark and the UK used to be much lower than in other similar countries. That's still the case here, but Denmark has climbed the rankings. So, how did they do it? Cancer survival in Denmark and the UK used to be much lower than in other similar countries. That's still the case here, but Denmark has climbed the rankings. So, how did they do it?

19 September 2025

• Charity News

Tackling children's and young people's cancers together: GOSH Charity joins C-Further

C-Further exists to bring together multiple groups with one clear purpose: developing more effective, targeted medicines for children and young people with cancer.  C-Further exists to bring together multiple groups with one clear purpose: developing more effective, targeted medicines for children and young people with cancer. 

18 September 2025

• For Researchers

A bridge for your career

Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme. Making the leap to form and lead your own lab can daunting – which is why CRUK created the Bridge to Academic Leadership (BAL) programme.

17 September 2025

• For Researchers

Level-up: Looking to epigenetics for the next immunotherapy breakthrough

Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted... Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted...

11 September 2025

• Health & Medicine

Just half of urgently referred cancer patients are being diagnosed on time

Our analysis of Faster Diagnosis Standard data shows that the NHS is only diagnosing half of cancers on time after urgent referrals. Our analysis of Faster Diagnosis Standard data shows that the NHS is only diagnosing half of cancers on time after urgent referrals.

11 September 2025

• Charity News

2024/25 in review: Cancer Research UK accelerates progress to outsmart cancer

Our annual reports and accounts for 2024/25 show we are making good progress in our mission to beat cancer. Our annual reports and accounts for 2024/25 show we are making good progress in our mission to beat cancer.

8 September 2025